The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Open accessAbstract
Lung cancer is the leading cause of cancer death worldwide, and adenocarcinoma is its most common histological subtype. Clinical and molecular evidence indicates that lung adenocarcinoma is a heterogeneous disease, which has important implications for treatment. Here we performed genome-scale DNA methylation profiling using the Illumina Infinium HumanMethylation27 platform on 59 matched lung adenocarcinoma/non-tumor lung pairs, with genome-scale verification on an independent set of tissues. We identified 766 genes showing altered DNA methylation between tumors and non-tumor lung. By integrating DNA methylation and mRNA expression data, we identified 164 hypermethylated genes showing concurrent down-regulation, and 57 hypomethylated genes showing increased expression. Integrated pathways analysis indicates that these genes are involved in cell differentiation, epithelial to mesenchymal transition, RAS and WNT signaling pathways, and cell cycle regulation, among others. Comparison of DNA methylation profiles between lung adenocarcinomas of current and never-smokers showed modest differences, identifying only LGALS4 as significantly hypermethylated and down-regulated in smokers. LGALS4, encoding a galactoside-binding protein involved in cell–cell and cell–matrix interactions, was recently shown to be a tumor suppressor in colorectal cancer. Unsupervised analysis of the DNA methylation data identified two tumor subgroups, one of which showed increased DNA methylation and was significantly associated with KRAS mutation and to a lesser extent, with smoking. Our analysis lays the groundwork for further molecular studies of lung adenocarcinoma by identifying novel epigenetically deregulated genes potentially involved in lung adenocarcinoma development/progression, and by describing an epigenetic subgroup of lung adenocarcinoma associated with characteristic molecular alterations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationPao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527 · cited 1×
“…treatments that specifically benefit patients defined by molecular subtypes such as EGFR, KRAS, BRAF, and ERBB2 muta- tions and EML4-ALK fusions (Pao et al. 2004, 2005a,b; Pao and Girard 2011), as well as observed prognostic gene expression sig- nature profiles (Bhattacharjee et al. 2001;…”
BackgroundBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
lumi: a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,019
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Self-citationConserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Self-citationCytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Pao, W., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., & Varmus, H. E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020017 · Cited by 1,516
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 1×
“Our findings support previous observations showing significant differences between the characteristics of genes that gain DNA methylation during tumorigenesis, vs. those that lose DNA methylation (Ohm et al. 2007; Schlesinger et al. 2007).”
ResultCancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
New driver mutations in non-small-cell lung cancer
Pao, W., & Girard, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70087-5 · Cited by 1,128
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Lipson, D., Capelletti, M., Yelensky, R., Otto, G., Parker, A., Jarosz, M., Curran, J. A., Balasubramanian, S., Bloom, T., Brennan, K. W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2673 · Cited by 869
New driver mutations in non-small-cell lung cancer
Tanoue, L. T. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2012.01.036 · Cited by 831
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Hou, J., Aerts, J., den Hamer, B., van IJcken, W., den Bakker, M., Riegman, P., van der Leest, C., van der Spek, P., Foekens, J. A., Hoogsteden, H. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010312 · Cited by 755
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Landi, M. T., Dracheva, T., Rotunno, M., Figueroa, J. D., Liu, H., Dasgupta, A., Mann, F. E., Fukuoka, J., Hames, M., Bergen, A. W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001651 · Cited by 680
ABCA3 Gene Mutations in Newborns with Fatal Surfactant Deficiency
Shulenin, S., Nogee, L. M., Annilo, T., Wert, S. E., Whitsett, J. A., & Dean, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032178 · Cited by 676
Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., Noushmehr, H., Lange, C. P. E., van Dijk, C. M., Tollenaar, R. A. E. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.969 · Cited by 660
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication
Breitling, L. P., Yang, R., Korn, B., Burwinkel, B., & Brenner, H. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.003 · Cited by 640
Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing
Brenet, F., Moh, M., Funk, P., Feierstein, E., Viale, A. J., Socci, N. D., & Scandura, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014524 · Cited by 635
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Nguyen, D. X., Chiang, A. C., Zhang, X. H.-F., Kim, J. Y., Kris, M. G., Ladanyi, M., Gerald, W. L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.04.030 · Cited by 613
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706550 · Cited by 593
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
Ju, Y. S., Lee, W.-C., Shin, J.-Y., Lee, S., Bleazard, T., Won, J.-K., Kim, Y. T., Kim, J.-I., Kang, J.-H., & Seo, J.-S. (2012) · Genome Research · doi:10.1101/gr.133645.111 · Cited by 484
Ahrendt, S. A., Decker, P. A., Alawi, E. A., Zhu, Y.-R., Sanchez-Cespedes, M., Yang, S. C., Haasler, G. B., Kajdacsy-Balla, A., Demeure, M. J., & Sidransky, D. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h · Cited by 449
(2002) · PubMed · Cited by 440
Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity
Toh, C.-K., Gao, F., Lim, W.-T., Leong, S.-S., Fong, K.-W., Yap, S.-P., Hsu, A. A. L., Eng, P., Koong, H.-N., Thirugnanam, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8033 · Cited by 379
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
Kupershmidt, I., Su, Q. J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Shekar, M., Wang, H., Park, J., Cui, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013066 · Cited by 368
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer
Lopez-Serra, P., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.354 · Cited by 360
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C. J., Cameron, J. L., Hruban, R. H., & Goggins, M. (2003) · PubMed · Cited by 336
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321
Galm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
Toyooka, S., Maruyama, R., Toyooka, K. O., McLerran, D., Feng, Z., Fukuyama, Y., Virmani, A. K., Zochbauer‐Muller, S., Tsukuda, K., Sugio, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10787 · Cited by 288
Self-citationRauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S. K., Kernstine, K. H., Riggs, A. D., & Pfeifer, G. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701059104 · Cited by 287
Identification of a Novel Biomarker, SEMA5A , for Non–Small Cell Lung Carcinoma in Nonsmoking Women
Lu, T.-P., Tsai, M.-H., Lee, J.-M., Hsu, C.-P., Chen, P.-C., Lin, C.-W., Shih, J.-Y., Yang, P.-C., Hsiao, C. K., Lai, L.-C., et al. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0332 · Cited by 283
Walker, B. A., Wardell, C. P., Chiecchio, L., Smith, E. M., Boyd, K. D., Neri, A., Davies, F. E., Ross, F. M., & Morgan, G. J. (2011) · Blood · doi:10.1182/blood-2010-04-279539 · Cited by 267
Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes
Leandro‐García, L. J., Leskelä, S., Landa, I., Montero‐Conde, C., López‐Jiménez, E., Letón, R., Cascón, A., Robledo, M., & Rodríguez‐Antona, C. (2010) · Cytoskeleton · doi:10.1002/cm.20436 · Cited by 265
Vaissière, T., Hung, R. J., Zaridze, D., Moukeria, A., Cuenin, C., Fasolo, V., Ferro, G., Paliwal, A., Hainaut, P., Brennan, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2489 · Cited by 258
Barbosa-Morais, N. L., Dunning, M. J., Samarajiwa, S. A., Darot, J. F. J., Ritchie, M. E., Lynch, A. G., & Tavaré, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp942 · Cited by 257
The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
Li, N., Grivennikov, S. I., & Karin, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.018 · Cited by 245
Mazieres, J., He, B., You, L., Xu, Z., & Jablons, D. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.040 · Cited by 244
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Yagi, K., Akagi, K., Hayashi, H., Nagae, G., Tsuji, S., Isagawa, T., Midorikawa, Y., Nishimura, Y., Sakamoto, H., Seto, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2006 · Cited by 223
Lung cancer epigenetics and genetics
Risch, A., & Plass, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23605 · Cited by 220
Zhang, W., Glöckner, S. C., Guo, M., Machida, E. O., Wang, D. H., Easwaran, H., Van Neste, L., Herman, J. G., Schuebel, K. E., Watkins, D. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6349 · Cited by 186
Self-citationHan, H., Cortez, C. C., Yang, X., Nichols, P. W., Jones, P. A., & Liang, G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr356 · Cited by 182
Hiraoka, N., Yamazaki–Itoh, R., Ino, Y., Mizuguchi, Y., Yamada, T., Hirohashi, S., & Kanai, Y. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.009 · Cited by 175
Ramachandran, V., Arumugam, T., Wang, H., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1320 · Cited by 175
Peroxiredoxins, a novel protein family in lung cancer
Lehtonen, S. T., Svensk, A., Soini, Y., Pääkkö, P., Hirvikoski, P., Kang, S. W., Säily, M., & Kinnula, V. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20294 · Cited by 173
Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array
Wikman, H., Kettunen, E., Seppänen, J. K., Karjalainen, A., Hollmén, J., Anttila, S., & Knuutila, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205726 · Cited by 171
The H-cadherin ( CDH13 ) gene is inactivated in human lung cancer
Sato, M., Mori, Y., Sakurada, A., Fujimura, S., & Horii, A. (1998) · Human Genetics · doi:10.1007/s004390050790 · Cited by 167
Toyooka, S., Tokumo, M., Shigematsu, H., Matsuo, K., Asano, H., Tomii, K., Ichihara, S., Suzuki, M., Aoe, M., Date, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2625 · Cited by 163
Self-citationSartor, M. A., Dolinoy, D. C., Jones, T. R., Colacino, J. A., Prince, M. E. P., Carey, T. E., & Rozek, L. S. (2011) · Epigenetics · doi:10.4161/epi.6.6.16216 · Cited by 159
Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
Hussain, M., Rao, M., Humphries, A. E., Hong, J. A., Liu, F., Yang, M., Caragacianu, D., & Schrump, D. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2807 · Cited by 159
Øster, B., Thorsen, K., Lamy, P., Wojdacz, T. K., Hansen, L. L., Birkenkamp‐Demtröder, K., Sørensen, K. D., Laurberg, S., Orntoft, T. F., & Andersen, C. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.25951 · Cited by 157
ABCA3 Is Critical for Lamellar Body Biogenesis in Vivo
Cheong, N., Zhang, H., Madesh, M., Zhao, M., Yu, K. R. T., Dodia, C., Fisher, A. B., Savani, R. C., & Shuman, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703927200 · Cited by 154
CpG island methylator phenotype (CIMP) in cancer: Causes and implications
Teodoridis, J. M., Hardie, C., & Brown, R. E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.022 · Cited by 153
Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
van Vlodrop, I. J. H., Niessen, H. E. C., Derks, S., Baldewijns, M. M. L. L., Criekinge, W. V., Herman, J. G., & van Engeland, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3394 · Cited by 149
The Retinoic Acid Synthesis Gene ALDH1a2 Is a Candidate Tumor Suppressor in Prostate Cancer
Kim, H., Lapointe, J., Kaygusuz, G., Ong, D. E., Li, C., van de Rijn, M., Brooks, J. D., & Pollack, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4562 · Cited by 147
Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
Osada, H., Tatematsu, Y., Yatabe, Y., Nakagawa, T., Konishi, H., Harano, T., Tezel, E., Takada, M., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205303 · Cited by 146
Huang, J., Zheng, D., Qin, F., Cheng, N., Chen, H., Wan, B., Wang, Y., Xiao, H., & Han, Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38012 · Cited by 140
Noordhuis, M. G., Fehrmann, R. S. N., Wisman, G. B. A., Nijhuis, E. R., van Zanden, J. J., Moerland, P. D., van Themaat, E. V. L., Volders, H. H., Kok, M., ten Hoor, K. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2320 · Cited by 132
Epigenetic remodeling during arsenical-induced malignant transformation
Jensen, T. J., Novák, P., Eblin, K. E., Gandolfi, A. J., & Futscher, B. W. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn102 · Cited by 131
Hu-Lowe, D. D., Chen, E., Zhang, L., Watson, K. D., Mancuso, P., Lappin, P., Wickman, G., Chen, J. H., Wang, J., Jiang, X., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1451 · Cited by 130
A novel adhesion molecule in human breast cancer cells: Voltage-gated Na+ channel β1 subunit
Chioni, A., Brackenbury, W. J., Calhoun, J. D., Isom, L. L., & Djamgoz, M. B. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.11.001 · Cited by 130
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis
Clark, S. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm051 · Cited by 129
Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
Gotô, Y., Shinjo, K., Kondo, Y., Shen, L., Toyota, M., Suzuki, H., Gao, W., An, B., Fujii, M., Murakami, H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1595 · Cited by 128
Suzuki, M., Shigematsu, H., Iizasa, T., Hiroshima, K., Nakatani, Y., Minna, J. D., Gazdar, A. F., & Fujisawa, T. (2006) · Cancer · doi:10.1002/cncr.21853 · Cited by 127
Self-citationIdentification and angiogenic role of the novel tumor endothelial marker CLEC14A
Mura, M., Swain, R. K., Zhuang, X. A., Vorschmitt, H., Reynolds, G. M., Durant, S., Beesley, J. F. J., Herbert, J. M. J., Sheldon, H., Andre, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.233 · Cited by 123
Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma
Larsen, J. E., Pavey, S. J., Passmore, L. H., Bowman, R., Hayward, N. K., & Fong, K. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2525 · Cited by 122
Galectin‐4 functions as a tumor suppressor of human colorectal cancer
Satelli, A., Rao, P. S., Thirumala, S. D., & Rao, U. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25750 · Cited by 120
Selamat, S. A., Galler, J. S., Joshi, A. D., Fyfe, M. N., Campan, M., Siegmund, K. D., Kerr, K. M., & Laird‐Offringa, I. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021443 · Cited by 119
Self-citationSilencing of Claudin-11 Is Associated with Increased Invasiveness of Gastric Cancer Cells
Agarwal, R., Mori, Y., Cheng, Y., Jin, Z., Olaru, A., Hamilton, J. P., David, S., Selaru, F. M., Yang, J. P., Abraham, J. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008002 · Cited by 116
Campan, M., Weisenberger, D. J., Trinh, B., & Laird, P. W. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-522-0_23 · Cited by 115
Self-citationVanderlaag, K. E., Hudak, S. A., Bald, L. N., Fayadat‐Dilman, L., Sathe, M., Grein, J., & Janatpour, M. J. (2010) · Breast Cancer Research · doi:10.1186/bcr2586 · Cited by 114
Wnt and Hedgehog Are Critical Mediators of Cigarette Smoke-Induced Lung Cancer
Lemjabbar‐Alaoui, H., Dasari, V. K., Sidhu, S., Mengistab, A., Finkbeiner, W. E., Gallup, M., & Basbaum, C. B. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000093 · Cited by 110
Pulling, L. C., Divine, K. K., Klinge, D. M., et al. (2003) · PubMed · Cited by 108
Sunaga, N., Imai, H., Shimizu, K., Shames, D. S., Kakegawa, S., Girard, L., Sato, M., Kaira, K., Ishizuka, T., Gazdar, A. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26164 · Cited by 103
Self-citationNovel candidate tumor marker genes for lung adenocarcinoma
Wang, K.-K., Liu, N., Radulovich, N., Wigle, D. A., Johnston, M. R., Shepherd, F. A., Minden, M. D., & Tsao, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205953 · Cited by 101
Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion
Wrage, M., Ruosaari, S., Eijk, P. P., Kaifi, J. T., Hollmén, J., Yekebas, E. F., Izbicki, J. R., Brakenhoff, R. H., Streichert, T., Riethdorf, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2188 · Cited by 98
Li, L., Lee, K.-M., Han, W., Choi, J., Lee, J., Kang, G. H., Park, S. K., Noh, D., Yoo, K.-Y., & Kang, D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq351 · Cited by 96
Sakthianandeswaren, A., Christie, M., D'Andreti, C., Tsui, C., Jorissen, R. N., Li, S., Fleming, N. I., Gibbs, P., Lipton, L. R., Malaterre, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2342 · Cited by 95
Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers
Divine, K. K., Pulling, L. C., Marron‐Terada, P. G., Liechty, K. C., Kang, T., Schwartz, A. G., Bocklage, T. J., Coons, T. A., Gilliland, F. D., & Belinsky, S. A. (2004) · International Journal of Cancer · doi:10.1002/ijc.20761 · Cited by 94
The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
Kerr, K. M., Galler, J. S., Hagen, J. A., Laird, P. W., & Laird‐Offringa, I. A. (2007) · Disease Markers · doi:10.1155/2007/985474 · Cited by 94
Self-citationFu, D.-Y., Wang, Z.-M., Li-Chen, Wang, B.-L., Shen, Z., Huang, W., & Shao, Z. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0339-8 · Cited by 90
Rab25 as a tumour suppressor in colon carcinogenesis
Goldenring, J. R., & Nam, K. T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605983 · Cited by 88
Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis
Tanaka, S., Pero, S. C., Taguchi, K., Shimada, M., Mori, M., Krag, D. N., & Arii, S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj105 · Cited by 86
Rohan, S. M., Tu, J. J., Kao, J., Mukherjee, P., Campagne, F., Zhou, X., Hyjek, E. M., Alonso, M. A., & Chen, Y. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1268 · Cited by 86
Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung
Tsou, J. A., Shen, L. Y. C., Siegmund, K. D., Long, T. I., Laird, P. W., Seneviratne, C. K., Koss, M. N., Pass, H. I., Hagen, J. A., & Laird‐Offringa, I. A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.08.003 · Cited by 86
Self-citationPromoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Kikuchi, S., Yamada, D., Fukami, T., Masuda, M., Sakurai‐Yageta, M., Williams, Y. N., Maruyama, T., Asamura, H., Matsuno, Y., Onizuka, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2206 · Cited by 85
Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation
Yue, W., Đačić, S., Sun, Q., Landreneau, R. J., Guo, M., Zhou, W., Siegfried, J. M., Yu, J., & Zhang, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0015 · Cited by 83
Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls
Pedersen, K. S., Bamlet, W. R., Oberg, A. L., de Andrade, M., Matsumoto, M., Tang, H. D., Thibodeau, S. N., Petersen, G. M., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018223 · Cited by 80
TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival
Toyoshima, Y., Karas, M., Yakar, S., Dupont, J., Helman, L. J., & LeRoith, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400661200 · Cited by 77
HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas
Shiraishi, M., Sekiguchi, A., Oates, A., Terry, M. J., & Miyamoto, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205453 · Cited by 75
Expression of the Lipid Transporters ABCA3 and ABCA1 is Diminished in Human Breast Cancer Tissue
Schimanski, S., Wild, P. J., Treeck, O., Horn, F., Sigrüener, A., Rudolph, C., Blaszyk, H., Klinkhammer‐Schalke, M., Ortmann, O., Hartmann, A., et al. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1241859 · Cited by 75
Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric Cancers
Sakakura, C., Hasegawa, K., Miyagawa, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0729 · Cited by 73
Tao, R. N., Li, ., Xin, J., Wu, J., Guo, J., Zhang, L., Jiang, L., Zhang, W., Yang, Z., & Li, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019862 · Cited by 72
Self-citationRodenhiser, D. I., Andrews, J. D., Kennette, W., Sadiković, B., Mendlowitz, A., Tuck, A. B., & Chambers, A. F. (2008) · Breast Cancer Research · doi:10.1186/bcr2121 · Cited by 72
Kaur, S., Leszczyńska, K. B., Abraham, S., Scarcia, M., Hiltbrunner, S., Marshall, C. J., Mavria, G., Bicknell, R., & Heath, V. L. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216341 · Cited by 68
The structure of GFRα1 domain 3 reveals new insights into GDNF binding and RET activation
Leppänen, V., Bespalov, M. M., Runeberg‐Roos, P., Puurand, Ü., Merits, A., Saarma, M., & Goldman, A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600174 · Cited by 68
Methylation Markers for Small Cell Lung Cancer in Peripheral Blood Leukocyte DNA
Wang, L., Aakre, J. A., Jiang, R., Marks, R. S., Wu, Y., Chen, J., Thibodeau, S. N., Pankratz, V. S., & Yang, P. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d6e0b3 · Cited by 66
DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines
Nishihara, H., Maeda, M., Oda, A., Tsuda, M., Sawa, H., Nagashima, K., & Tanaka, S. (2002) · Blood · doi:10.1182/blood-2001-11-0032 · Cited by 64
Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc–Mediated Antitumor Activity in Lung Cancer
Andersson, Å., Srivastava, M. K., Harris‐White, M. E., Huang, M., Zhu, L. X., Elashoff, D. A., Strieter, R. M., Dubinett, S. M., & Sharma, S. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3346 · Cited by 52
Shiba‐Ishii, A., Kano, J., Morishita, Y., Sato, Y., Minami, Y., & Noguchi, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25907 · Cited by 49
Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer
Ibragimova, I., de Cáceres, I. I., Hoffman, A. M., Potapova, A., Dulaimi, E., Al‐Saleem, T., Hudes, G. R., Ochs, M. F., & Cairns, P. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0039 · Cited by 49
Mining the Epigenome for Methylated Genes in Lung Cancer
Tessema, M., & Belinsky, S. A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200805-045th · Cited by 44
Gene expression profiling in sinonasal adenocarcinoma
Tripodi, D., Redon, S., Renaudin, K., Ferron, C., Malard, O., Guisle, I., Sebille, V., Verger, C., Géraut, C., & Gratas, C. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-65 · Cited by 43
Clausen, K. A., Blish, K. R., Birse, C. E., Triplette, M., Kute, T. E., Russell, G. B., D’Agostino, R. B., Miller, L. D., Torti, F. M., & Torti, S. V. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1261-9 · Cited by 42
Kobayashi, K., Nishioka, M., Kohno, T., Nakamoto, M., Maeshima, A., Aoyagi, K., Sasaki, H., Takenoshita, S., Sugimura, H., & Yokota, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207433 · Cited by 41
Ishigaki-Suzuki, S., Numayama-Tsuruta, K., Kuramasu, A., Sakurai, E., Makabe, Y., Shimura, S., Shirato, K., Igarashi, K., Watanabe, T., & Ohtsu, H. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.14.2627 · Cited by 40
Shimizu, H., Horii, A., Sunamura, M., Motoi, F., Egawa, S., Unno, M., & Fukushige, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.121 · Cited by 39
Remmelink, M., Mijatovic, T., Gustin, A., Mathieu, A., Rombaut, K., Robert Kiss, A., Salmon, I. J., & Decaestecker, C. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.247 · Cited by 30
VSGP/F-Spondin: A New Ovarian Cancer Marker
Pyle-Chenault, R. A., Stolk, J. A., Molesh, D. A., Harlan, D., McNeill, P. D., Repasky, E. A., Jiang, Z., Fanger, G. R., & Xu, J. (2005) · Tumor Biology · doi:10.1159/000087379 · Cited by 30
Sakhinia, E., Farahangpour, M., Tholouli, E., Yin, J. A. L., Hoyland, J. A., & Byers, R. J. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031161 · Cited by 28
Rui, X., Tsao, J., Scheys, J. O., Hammer, G. D., & Schimmer, B. P. (2008) · Endocrinology · doi:10.1210/en.2008-0203 · Cited by 25
Investigating the Epigenetic Effects of a Prototype Smoke-Derived Carcinogen in Human Cells
Tommasi, S., Kim, S.-I., Zhong, X., Wu, X., Pfeifer, G. P., & Nia, A. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010594 · Cited by 21
Vitale, L., Frabetti, F., Huntsman, S. A., Canaider, S., Casadei, R., Lenzi, L., Facchin, F., Carinci, P., Zannotti, M., Coppola, D., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-66 · Cited by 18
Cited by
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Coelho, M. A., de Carné Trécesson, S., Rana, S., Zecchin, D., Moore, C., Molina-Arcas, M., East, P., Spencer-Dene, B., Nye, E., Barnouin, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.016 · Cited by 653
Rousseaux, S., Debernardi, A., Jacquiau, B., Vitte, A.-L., Vesin, A., Nagy-Mignotte, H., Moro-Sibilot, D., Brichon, P.-Y., Lantuejoul, S., Hainaut, P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005723 · Cited by 586
Sun, M., Nie, F., Wang, Y., Zhang, Z., Hou, J., He, D., Xie, M., Xu, L., De, W., Wang, Z., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0356 · Cited by 469
Genetic alterations defining NSCLC subtypes and their therapeutic implications
Pikor, L. A., Ramnarine, V. R., Lam, S., & Lam, W. L. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.025 · Cited by 375
Self-citationAge-associated epigenetic drift: implications, and a case of epigenetic thrift?
Teschendorff, A. E., West, J., & Beck, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt375 · Cited by 316
Metadata
- Authors
- Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., Siegmund, K. D., Koss, M. N., Hagen, J. A., Lam, W. L., Lam, S., Gazdar, A. F., & Laird-Offringa, I. A.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-05-21
- Volume
- 22
- Issue
- 7
- Pages
- 1197-1211
- ISSN
- 1088-9051 (ISSN-L)
- OpenAlex
- W2099755355
- Cited by
- 521
- References
- 140
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.